These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9315522)

  • 1. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women.
    Nguyen TT; Ellefson RD; Hodge DO; Bailey KR; Kottke TE; Abu-Lebdeh HS
    Circulation; 1997 Sep; 96(5):1390-7. PubMed ID: 9315522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of macrovascular disease in patients with type 2 diabetes mellitus.
    Abu-Lebdeh HS; Hodge DO; Nguyen TT
    Mayo Clin Proc; 2001 Jul; 76(7):707-12. PubMed ID: 11444403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein (a) as a risk factor for coronary artery disease in women and elderly patients].
    Serdar A; Yeşilbursa D; Serdar Z
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):259-63; AXV-XVI. PubMed ID: 12101835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis.
    Foody JM; Milberg JA; Pearce GL; Sprecher DL
    Atherosclerosis; 2000 Dec; 153(2):445-51. PubMed ID: 11164434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.
    Gurdasani D; Sjouke B; Tsimikas S; Hovingh GK; Luben RN; Wainwright NW; Pomilla C; Wareham NJ; Khaw KT; Boekholdt SM; Sandhu MS
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3058-65. PubMed ID: 23065826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Lipoprotein(a) levels between elderly and middle-aged men with coronary artery disease.
    Cicek H; Bayil S; Zer Y; Celik A; Geyikli I
    Ann N Y Acad Sci; 2007 Apr; 1100():179-84. PubMed ID: 17460176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein(a) as a risk factor for cardiovascular disease in elderly patients with diabetes].
    Miyao M; Araki A; Hattori A; Miyachi T; Inoue J; Horiuchi T; Nakamura T; Ueda S; Nakahara K; Matsushita S; Ito H
    Nihon Ronen Igakkai Zasshi; 1997 Mar; 34(3):185-91. PubMed ID: 9155192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.
    Bostom AG; Cupples LA; Jenner JL; Ordovas JM; Seman LJ; Wilson PW; Schaefer EJ; Castelli WP
    JAMA; 1996 Aug; 276(7):544-8. PubMed ID: 8709403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.
    Shai I; Schulze MB; Manson JE; Stampfer MJ; Rifai N; Hu FB
    Diabetologia; 2005 Aug; 48(8):1469-76. PubMed ID: 15971061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
    Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
    Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age.
    Sunayama S; Daida H; Mokuno H; Miyano H; Yokoi H; Lee YJ; Sakurai H; Yamaguchi H
    Circulation; 1996 Sep; 94(6):1263-8. PubMed ID: 8822978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.
    Bostom AG; Gagnon DR; Cupples LA; Wilson PW; Jenner JL; Ordovas JM; Schaefer EJ; Castelli WP
    Circulation; 1994 Oct; 90(4):1688-95. PubMed ID: 7923652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lp(a) lipoprotein, vascular disease, and mortality in the elderly.
    Ariyo AA; Thach C; Tracy R;
    N Engl J Med; 2003 Nov; 349(22):2108-15. PubMed ID: 14645638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study.
    Hopkins PN; Hunt SC; Schreiner PJ; Eckfeldt JH; Borecki IB; Ellison CR; Williams RR; Siegmund KD
    Atherosclerosis; 1998 Dec; 141(2):333-45. PubMed ID: 9862182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a).
    Solfrizzi V; Colacicco AM; D'Introno A; Capurso C; Chirico M; Frisardi V; Cacciapaglia M; Vendemiale G; Capurso A; Panza F
    Rejuvenation Res; 2009 Dec; 12(6):395-402. PubMed ID: 20014954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.